ThinkSono secures £2.1m seed investment led by id4 ventures
The medtech firm has raised £2.1m from investors including id4 ventures and Brandenburg Kapital to support its ultrasound software.
ThinkSono develops medical technology specialising in ultrasound artificial intelligence guidance solutions. The firm has built software that allows non-ultrasound trained medical staff to scan patients.
ThinkSono has secured £2.1m in a seed funding round led by id4 ventures. The capital injection includes participation from Brandenburg Kapital, Calm Storm Ventures, Dubai Angel Investors, CrowdCube, and Cur8 Capital alongside various angel investors and vascular surgery clinicians.
The fresh funds arrive alongside the attainment of the Class IIb CE mark for the company flagship product, the ThinkSono Guidance system. The software allows healthcare personnel without ultrasound training to scan patients suspected of deep vein thrombosis and forward the data for clinical review.
The company is also pursuing regulatory approval in the United States, having formed partnerships with NYU Langone Health and Temple Health to accelerate its entry into the American market.
From the founder
"We are thrilled to announce this significant funding milestone and the achievement of key regulatory milestones for our ThinkSono Guidance system. This funding will enable us to further advance our mission of revolutionizing medical imaging technology while our partnerships with NYU Langone Health and Temple Health underscore our commitment to delivering innovative solutions that ultimately improve patient outcomes."
Fouad Al Noor
CEO and co-founder at ThinkSono
Investors
id4 ventures
Brandenburg Kapital
Calm Storm Ventures
Dubai Angel Investors
CrowdCube
Cur8 Capital
Categories
About the company
ThinkSono
ThinkSono builds real-time ultrasound artificial intelligence software for healthcare staff.